Innovations

Immune T cell defense is coping with COVID-19 variants of concern (for now)

0
Digital transformation conceptual for next generation technology era

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.

Clinician nudge ups initiation of statin prescribing in primary care

Previous article

Early life experiences can affect gene activity more than half a lifetime later

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations